Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Recruiting 8Active not recruiting 6Unknown 3Terminated 3Enrolling by invitation 1Available 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Neuroendocrine 2Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Melanoma 1Lymphoma 1Gastro-enteropancreatic neuroendocrine tumor 1Disease Progression 1Carcinoma 1Carcinoid Tumor 1Adenoma, Islet Cell 1Adenocarcinoma 1

Interventions

PM 01183 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Adenoma, Islet Cell × NET × Clear all
NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation
46 enrolled
EndocrineNET

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡